Related Experiment Video
Updated: Jan 18, 2026

08:41
Unilateral Pyramidotomy of the Corticospinal Tract in Rats for Assessment of Neuroplasticity-inducing Therapies
Published on: December 15, 2014
16.3K
Cuneiform Nucleus Stimulation Can Assist Gait Training to Promote Locomotor Recovery in Individuals With Incomplete
Anna-Sophie Hofer1,2, Lennart H Stieglitz1, Marc Bolliger3
1Department of Neurosurgery, Clinical Neuroscience Center, University Hospital Zurich, Zurich, Switzerland.
Annals of Neurology
|September 10, 2025
Summary
Deep brain stimulation of the cuneiform nucleus (CNF-DBS) shows promise for improving walking in spinal cord injury (SCI) patients. This novel approach may enhance locomotor training and recovery in individuals with chronic tetraplegia.
Area of Science:
- Neuroscience
- Neurology
- Rehabilitation Medicine
Background:
- Incomplete spinal cord injury (SCI) often impairs stepping ability, limiting locomotor training efficacy and leading to wheelchair dependence.
- The cuneiform nucleus (CNF) is a crucial mesencephalic center for locomotor control, modulating spinal centers via the reticulospinal tract.
- Unilateral CNF deep brain stimulation (DBS) has shown potential in rodent models to induce stepping and improve gait after SCI.
Purpose of the Study:
- To investigate the therapeutic potential of unilateral CNF-DBS in augmenting training and improving gait in human patients with incomplete SCI.
- To translate findings from animal models to clinical application in non-ambulatory individuals with chronic tetraplegia.
Main Methods:
- A clinical trial (NCT03053791) involving unilateral CNF-DBS in conjunction with 6 months of locomotor training.
- Assessment of 2 individuals with chronic tetraplegia, evaluating effects with and without stimulation.
- Primary endpoint: change in walking distance during the 6-Minute Walking Test (6MWT) after 6 months.
Main Results:
- Patient 1 achieved the primary endpoint in the off-stimulation condition.
- Patient 2 achieved the primary endpoint in both off- and on-stimulation conditions.
- No serious adverse events were reported during the study.
Conclusions:
- Unilateral CNF-DBS was well-tolerated in the first two patients with chronic tetraplegia.
- The findings suggest CNF-DBS has therapeutic potential for improving gait in SCI.
- Lessons learned are being implemented for future patient cohorts.

